Arbutus Biopharma Corporation logo
Arbutus Biopharma Corporation ABUS
€ 4.04 -1.56%

Quartalsbericht 2025-Q3
hinzugefügt 13.11.2025

report update icon

Arbutus Biopharma Corporation Kurzfristige Verbindlichkeiten 2011-2026 | ABUS

Kurzfristige Verbindlichkeiten Jährlich Arbutus Biopharma Corporation

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
22.5 M 32.9 M 11.2 M 9.54 M 7.83 M 11.2 M 14.6 M 10.6 M 10.6 M 20.2 M - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
32.9 M 7.83 M 15.1 M

Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name Kurzfristige Verbindlichkeiten Preis % 24h Marktkapitalisierung Land
AgeX Therapeutics AgeX Therapeutics
AGE
5.91 M - -10.17 % $ 12.2 K usaUSA
AIkido Pharma AIkido Pharma
AIKI
3.78 M - 1.93 % $ 17.4 M usaUSA
Aclaris Therapeutics Aclaris Therapeutics
ACRS
31.6 M $ 2.83 -5.98 % $ 219 M usaUSA
AlloVir AlloVir
ALVR
5.24 M - 4.14 % $ 49.1 M usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
534 M $ 11.02 -2.39 % $ 713 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
2.38 M - -11.43 % $ 502 K usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
58 M - - $ 2.17 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
54.1 M - - $ 1.01 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
816 K - -52.27 % $ 4.45 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
60.7 M $ 1.92 -3.52 % $ 490 M britainBritain
AVROBIO AVROBIO
AVRO
6.35 M - 1083.1 % $ 745 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.05 M $ 0.2 -0.05 % $ 435 M israelIsrael
BioDelivery Sciences International BioDelivery Sciences International
BDSI
82.4 M - -4.8 % $ 255 M usaUSA
BioVie BioVie
BIVI
2.27 M $ 1.23 6.03 % $ 1.82 M usaUSA
Athersys Athersys
ATHX
29.9 M - 3.77 % $ 22.4 M usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
20 M $ 11.22 -5.4 % $ 739 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Certara Certara
CERT
146 M $ 8.79 -0.23 % $ 1.41 B usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
3.77 M - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
45.5 M - -7.31 % $ 87 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
13 M - 1052.0 % $ 415 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.93 M - 4.01 % $ 150 M canadaCanada
Celldex Therapeutics Celldex Therapeutics
CLDX
39.5 M $ 27.12 -0.15 % $ 1.75 M usaUSA
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
72.8 M - -15.15 % $ 60.3 M britainBritain
bluebird bio bluebird bio
BLUE
200 M - - $ 546 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
14 M - -10.95 % $ 876 K usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
174 M $ 26.21 -2.13 % $ 1.27 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
2.21 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Anika Therapeutics Anika Therapeutics
ANIK
31.1 M $ 9.54 -0.73 % $ 140 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
66.3 M - -6.81 % $ 3.04 B usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
141 M $ 36.56 5.06 % $ 3.77 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
19 M - 2.71 % $ 14 M usaUSA
CorMedix CorMedix
CRMD
11.4 M $ 12.24 5.25 % $ 623 M usaUSA
Axon Enterprise Axon Enterprise
AXON
1.68 B $ 559.07 -1.56 % $ 42.3 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
Cellectar Biosciences Cellectar Biosciences
CLRB
25.4 M $ 3.39 14.8 % $ 41.4 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
63.1 M $ 2.74 5.38 % $ 17.2 M usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
20.1 M - - $ 169 M usaUSA